Literature DB >> 31871365

LEGAL AND ETHICAL IMPLICATIONS OF CRISPR APPLICATIONS IN PSYCHIATRY.

Alexandra L Foulkes1, Takahiro Soda2, Martilias Farrell3, Paola Giusti-Rodríguez4, Gabriel Lázaro-Muñoz5.   

Abstract

Gene-environment interactions play a key role in how psychiatric disorders manifest and develop. Psychiatric genetics researchers are making progress in identifying genomic correlates of many disorders. And recently, the field of genetics has given rise to a technology that many claim will revolutionize the biological sciences and propel the field into a transformative phase: the powerful gene-editing tool known as CRISPR-Cas9. This Article illustrates which psychiatric conditions are likely to make an attractive target for CRISPR as the technology evolves and CRISPR therapies becomes a viable tool to manage or prevent disorders in a clinical setting. We examine the potential scientific and clinical challenges of applying CRISPR in the mental health context, along with the regulatory, ethical, and legal issues that might arise as a consequence of these applications.

Entities:  

Year:  2019        PMID: 31871365      PMCID: PMC6927684     

Source DB:  PubMed          Journal:  North Carol Law Rev        ISSN: 0029-2524


  3 in total

Review 1.  Advances and Perspectives in the Application of CRISPR-Cas9 in Livestock.

Authors:  Abdul Jabbar; Farheen Zulfiqar; Mahnoor Mahnoor; Nadia Mushtaq; Muhammad Hamza Zaman; Anum Salah Ud Din; Musarrat Abbas Khan; Hafiz Ishfaq Ahmad
Journal:  Mol Biotechnol       Date:  2021-05-26       Impact factor: 2.695

Review 2.  Harnessing the potential of CRISPR-based platforms to advance the field of hospital medicine.

Authors:  Matthew W McCarthy
Journal:  Expert Rev Anti Infect Ther       Date:  2020-05-04       Impact factor: 5.091

Review 3.  CRISPR Gene-Editing Models Geared Toward Therapy for Hereditary and Developmental Neurological Disorders.

Authors:  Poh Kuan Wong; Fook Choe Cheah; Saiful Effendi Syafruddin; M Aiman Mohtar; Norazrina Azmi; Pei Yuen Ng; Eng Wee Chua
Journal:  Front Pediatr       Date:  2021-03-11       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.